124 research outputs found
Effect of Image Forces on Polyelectrolyte Adsorption at a Charged Surface
The adsorption of flexible and highly charged polyelectrolytes onto
oppositely charged planar surfaces is investigated by means of Monte Carlo
simulations. The effect of image forces stemming from the dielectric
discontinuity at the substrate interface is considered. The influence, at fixed
polyelectrolyte volume fraction, of chain length and surface-charge density is
also considered. A detailed structural study, including monomer and fluid
charge distributions, is provided. It is demonstrated that image forces can
considerably reduce the degree of polyelectrolyte adsorption and concomitantly
inhibit the charge inversion of the substrate by polyelectrolytes.Comment: 19 pages - 7 eps figs - RevTex 4 - submitted for publicatio
Differences in treatment of stage I colorectal cancers: a population-based study of colorectal cancers detected within and outside of a screening program
Background Screen-detected colorectal cancers (CRCs) are often treated less invasively than stage-matched nonscreen-detected CRCs, but the reasons for this are not fully understood. This study evaluated the treatment of stage I CRCs detected within and outside of the screening program in the Netherlands. Methods Data from the Netherlands Cancer Registry for all stage I CRCs diagnosed between January 1, 2008 and December 31, 2020 were analyzed, comparing patient, tumor, and treatment characteristics of screen-detected and nonscreen-detected stage I CRCs. Multivariable logistic regression was used to assess the association between treatment (local excision only vs. surgical oncologic resection) and patient and tumor characteristics, stratified for T stage and tumor location. Results Screen-detected stage I CRCs were relatively more often T1 than T2 compared with non-screen-detected stage I CRCs (66.9 % vs. 53.3 %; P 0.001). When only T1 tumors were considered, both screen-detected colon and rectal cancers were more often treated with local excision only than non-screen-detected T1 cancers (odds ratio [OR] 2.19, 95%CI 1.93 2.49; and OR 1.29, 95 %CI 1.05 1.59, respectively), adjusted for sex, tumor location, lymphovascular invasion (LVI) status, and tumor differentiation. Conclusions Less invasive treatment of screen-detected stage I CRC is partly explained by the higher rate of T1 cancers compared with non-screen-detected stage I CRCs. T1 stage I screen-detected CRCs were also more likely to undergo less invasive treatment than non-screen-detected CRCs, adjusted for risk factors such as LVI and tumor differentiation. Future research should investigate whether the choice of local excision was related to unidentified cancerrelated factors or the expertise of the endoscopists
The Dutch Consumer Quality Index: an example of stakeholder involvement in indicator development
Background:
Like in several other Western countries, in the Dutch health care system regulated competition has been
introduced. In order to make this work, comparable information is required about the performance of health care
providers in terms of effectiveness, safety and patient experiences. Without further coordination, external actors will all
try to force health care providers to be transparent. For health care providers this might result in a situation in which
they have to deliver data for several sets of indicators, defined by different actors. Therefore, in the Netherlands an effort
is made to define national sets of performance indicators and related measuring instruments. In this article, the
following questions are addressed, using patient experiences as an example:
- When and how are stakeholders involved in the development of indicators and instruments that measure the
patients' experiences with health care providers?
- Does this involvement lead to indicators and instruments that match stakeholders' information needs?
Discussion:
The Dutch experiences show that it is possible to implement national indicator sets and to reach
consensus about what needs to be measured. Preliminary evaluations show that for health care providers and health
insurers the benefits of standardization outweigh the possible loss of tailor-made information. However, it has also
become clear that particular attention should be given to the participation of patient/consumer organisations.
Summary:
Stakeholder involvement is complex and time-consuming. However, it is the only way to balance the
information needs of all the parties that ask for and benefit from transparency, without frustrating the health care
system.
Oncologic outcomes of screen-detected and non-screen-detected T1 colorectal cancers
Background:The incidence of T1 colorectal cancer (CRC) has increased with the implementation of CRC screening programs. It is unknown whether the outcomes and risk models for T1 CRC based on non-screen-detected patients can be extrapolated to screen-detected T1 CRC. This study aimed to compare the stage distribution and oncologic outcomes of T1 CRC patients within and outside the screening program. Methods: Data from T1 CRC patients diagnosed between 2014 and 2017 were collected from 12 hospitals in the Netherlands. The presence of lymph node metastasis (LNM) at diagnosis was compared between screen-detected and non-screen-detected patients using multivariable logistic regression. Cox proportional hazard regression was used to analyze differences in the time to recurrence (TTR), metastasis-free survival (MFS), cancer-specific survival (CSS), and overall survival. Additionally, the performance of conventional risk factors for LNM was evaluated across the groups. Results: 1803 patients were included (1114 [62%] screendetected), with median follow-up of 51 months (interquartile range 30). The proportion of LNM did not significantly differ between screen- and non-screen-detected patients (12.6% vs. 8.9%; odds ratio 1.41; 95%CI 0.89-2.23); a prediction model for LNM performed equally in both groups. The 3- and 5-year TTR, MFS, and CSS were similar for patients within and outside the screening program. However, overall survival was significantly longer in screen-detected T1 CRC patients (adjusted hazard ratio 0.51; 95%CI 0.38- 0.68). Conclusions: Screen-detected and non-screen-detected T1 CRCs have similar stage distributions and oncologic outcomes and can therefore be treated equally. However, screen-detected T1 CRC patients exhibit a lower rate of non-CRC-related mortality, resulting in longer overall survival.</p
Holographic isotropization linearized
The holographic isotropization of a highly anisotropic, homogeneous, strongly
coupled, non-Abelian plasma was simplified in arXiv:1202.0981 by linearizing
Einstein's equations around the final, equilibrium state. This approximation
reproduces the expectation value of the boundary stress tensor with a 20%
accuracy. Here we elaborate on these results and extend them to observables
that are directly sensitive to the bulk interior, focusing for simplicity on
the entropy production on the event horizon. We also consider
next-to-leading-order corrections and show that the leading terms alone provide
a better description of the isotropization process for the states that are
furthest from equilibrium.Comment: 30 pages, 14 figures; v2: minor changes in the text, matches the
published versio
- …